Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
04/2014
04/01/2014CA2556436C Process for preparing anit-a.beta. antibody
04/01/2014CA2544692C Anti-glypican 3 antibody
04/01/2014CA2544368C Methods of therapy for b cell-related cancers
04/01/2014CA2531231C Uranium-chelating peptides and uses thereof
04/01/2014CA2515444C Immunoglobulin formulation and method of preparation thereof
04/01/2014CA2504920C Ligand for g-protein coupled receptor fprl2 and uses thereof
04/01/2014CA2498523C Human cd3-specific antibody with immunosuppressive properties
04/01/2014CA2493928C Nucleic acids and corresponding proteins entitled 273p4b7 useful in treatment and detection of cancer
04/01/2014CA2488682C Gene differentially expressed in breast and bladder cancer and encoded polypeptides
04/01/2014CA2432942C Carbohydrate deficient transferrin (cdt)-specific antibodies, their preparation and use
04/01/2014CA2420062C Erbb4 antagonists
04/01/2014CA2413354C Neurotoxic a.beta. oligomers in alzheimer's disease
03/2014
03/27/2014WO2014047624A1 Anti-ddr1 antibodies
03/27/2014WO2014047357A1 Modified fc polypeptides, fc conjugates, and methods of use thereof
03/27/2014WO2014047231A1 Anti-cd3 antibodies, bispecific antigen-binding molecules that bind cd3 and cd20, and uses thereof
03/27/2014WO2014047222A2 Methods for identifying antibodies with reduced immunogenicity
03/27/2014WO2014047124A1 Compositions and methods for delivery of antigens to plasmacytoid dendritic cells
03/27/2014WO2014046994A1 Compositions and methods for antigen targeting to cd180
03/27/2014WO2014046966A1 Beclin 1 phosphorylation
03/27/2014WO2014045266A1 Treatment of type 2 diabetes and related conditions
03/27/2014WO2014045226A1 Clostridium difficile polypeptides as vaccine
03/27/2014WO2014044768A1 Treatment for rheumatoid arthritis
03/27/2014WO2014044686A1 Kir3dl2 binding agents
03/27/2014WO2014044681A1 Kir3dl2 binding agents
03/27/2014WO2014044184A1 Protein for detecting type 1 diabetes mellitus and partial peptide thereof
03/27/2014WO2014004427A3 Anti-egfr antibodies and uses thereof
03/27/2014WO2014004336A3 Split inteins, conjugates and uses thereof
03/27/2014WO2013184614A3 Peptide conjugates for treating pain
03/27/2014WO2013181618A3 Methods to treat alzheimer's disease using apoe inhibitors
03/27/2014WO2013177593A3 Identification of mhc class i phospho-peptide antigens from breast cancer utilizing shla technology and complementary enrichment strategies
03/27/2014WO2013165894A3 St2l antagonists and methods of use
03/27/2014US20140090094 Modulators of slc22a7
03/27/2014US20140088408 Phage antibodies to radiation-inducible neoantigens
03/27/2014US20140088296 Il-18 binding proteins
03/27/2014US20140088295 Anti-cd3 antibodies, bispecific antigen-binding molecules that bind cd3 and cd20, and uses thereof
03/27/2014US20140087423 Method for Controlling the Main Complex N-Glycan Structures and the Acidic Variants and Variability in Bioprocesses Producing Recombinant Proteins
03/27/2014US20140087422 Nucleic acids related to fusion proteins
03/27/2014US20140087393 Methods for predicting pregnancy outcome in a subject by hcg assay
03/27/2014US20140087392 Glycosyl transferase from chinese hamster and related methods
03/27/2014US20140087384 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
03/27/2014US20140086937 Immunological control of beta-amyloid levels in vivo
03/27/2014US20140086935 Human TIMP-1 Antibodies
03/27/2014US20140086934 Method for treating intraocular neovascular diseases
03/27/2014US20140086928 Antigenic GM-CSF Peptides and Antibodies to GM-CSF
03/27/2014US20140086927 Novel epitope and mechanism of antigen-antibody interaction in an influenza virus
03/27/2014US20140086923 Antibodies Directed Against ICOS and Uses Thereof
03/27/2014US20140086922 Anti-il-12/il-23 antibodies
03/27/2014US20140086920 Antagonist Antibodies against GDF-8 and Uses in Treatment of ALS and Other GDF-8 Associated Disorders
03/27/2014US20140086919 Methods and compositons for regulating iron homeostasis by modulation of bmp-6
03/27/2014US20140086916 METHOD FOR PREPARING Fc CONTAINING POLYPEPTIDES HAVING IMPROVED PROPERTIES
03/27/2014US20140086914 TREATMENT METHODS USING c-MET ANTIBODIES
03/27/2014US20140086913 Anti-ddr1 antibodies
03/27/2014US20140086912 Humanized anti-interleukin 3 receptor alpha chain antibodies
03/27/2014US20140086906 Optimized Antibodies That Target CD19
03/27/2014US20140086905 Immunological compositions as cancer therapeutics
03/27/2014US20140086904 Humanized Anti-TNF-alpha Antibody and Antigen-Binding Fragment (Fab) Thereof and Use of the Same
03/27/2014US20140086871 Ultralong complementarity determining regions and uses thereof
03/27/2014US20140086846 Contrast enhancement agents and method of use thereof
03/27/2014US20140086835 Methods and Compositions for Heptameric Targeting Ligands
03/27/2014US20140086830 Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R)
03/27/2014US20140086829 Recombinant Antibodies to the Vascular Endothelial Growth Factor (VEGF) which are Obtained by Means of Mutagenesis of Variable Regions
03/26/2014EP2711375A1 Human Antigen Binding Proteins that bind Beta-Klotho, FGF Receptors and complexes thereof
03/26/2014EP2711018A1 Engineered Fc regions for site-specific conjugation
03/26/2014EP2710376A2 Antibodies to 25-hydroxyvitamin d2 and d3 and uses thereof
03/26/2014EP2710042A2 Multi-specific fab fusion proteins and methods of use
03/26/2014EP2710041A1 Assay to determine lrrk2 activity in parkinson's disease
03/26/2014EP2710040A1 Anti-human-her3 antibodies and uses thereof
03/26/2014EP2710039A2 Anti-cgrp compositions and use thereof
03/26/2014EP2710038A1 COMBINATIONS OF ANTI ErbB ANTIBODIES FOR THE TREATMENT OF CANCER
03/26/2014EP2710037A2 Integrin alpha-2 binding agents and use thereof to inhibit cancer cell proliferation
03/26/2014EP2710036A1 Antibodies against tropomyosin-related kinase b receptors
03/26/2014EP2710035A1 Fgfr1 agonists and methods of use
03/26/2014EP2710034A1 Use of anti-cd19 maytansinoid immunoconjugate antibody for the treatment of b-cell malignancies symptoms
03/26/2014EP2710033A1 Human immunodeficiency virus neutralizing antibodies and methods of use thereof
03/26/2014EP2710032A1 Modified glycoproteins
03/26/2014EP2710030A1 Rbm3 in bladder cancer
03/26/2014EP2710026A2 Immunoglobulin reduced in thrombogenic agents and preparation thereof
03/26/2014EP2709663A2 Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
03/26/2014EP2709661A1 Therapeutic anti-igf1r combinations
03/26/2014EP2709659A1 Method for detecting infections
03/26/2014EP2709655A1 Vaccine preparation containing trifunctional antibodies with antigen immunogenicity enhancer properties
03/26/2014EP2535358A9 Radioactive metal-labeled anti-cadherin antibody
03/26/2014CN1938045B Use of cd40 antibody for treating autoimmune diseases, inflammatory diesease and organ transplanting rejection
03/26/2014CN103687945A Anti-B7-H3 antibody
03/26/2014CN103687879A Multivalent antigen-binding FV molecule
03/26/2014CN103687878A Inhibitory anti-factor XII/XIIA monoclonal antibodies and their uses
03/26/2014CN103687877A Variants of humanized immunomodulatory monoclonal antibodies
03/26/2014CN103687876A Monoclonal antibodies specific for beta-amyloid x-37 and uses thereof
03/26/2014CN103687875A Compositions for preventing and/or treating an infection by an hiv-1 virus
03/26/2014CN103687874A Method for preparing a polyvalent-immunoglobulin concentrate
03/26/2014CN103687873A Identifying affinity-matured human antibodies
03/26/2014CN103687872A Prostate-specific membrane antigen binding proteins and related compositions and methods
03/26/2014CN103687871A Means and methods for diagnosing and treating multiple sclerosis
03/26/2014CN103687870A Biomarkers for in vitro prognosis and diagnosis of graft and transplant rejection
03/26/2014CN103687620A Compositions for inhibiting masp-2 dependent complement acitivation
03/26/2014CN103675294A Novel tumour serum marker and application thereof
03/26/2014CN103667321A Protein preparation method for improving immune effect of M2 pyruvate kinase
03/26/2014CN103667318A Preparation method of chlamydophila pneumoniae-specific antigen polypeptide
03/26/2014CN103665165A Bispecific antibody targeting human CD47-SIRP alpha signal passage and preparation method and application thereof
03/26/2014CN103665164A ELISA (enzyme-linked immunosorbent assay) kit for detecting Tim-3
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 1494